IL2 and cancer: Furthermore, exploring combination therapies—IL-2/IL-2R-targeted therapies coupled with traditional cancer treatments like chemotherapy, radiotherapy, or other immunotherapies like checkpoint inhibitors—could optimize cancer treatment efficacy.